Status:
COMPLETED
Triamcinolone Packing Following Endoscopic Sinus Surgery
Lead Sponsor:
University of California, Los Angeles
Conditions:
Sinusitis
Eligibility:
All Genders
18+ years
Brief Summary
Endoscopic sinus surgery (ESS) is a well-established treatment strategy for medically refractory chronic rhinosinusitis. Middle meatus spacers are currently used following ESS to prevent scarring, syn...
Detailed Description
Introduction Endoscopic sinus surgery (ESS) is a well-established treatment strategy for medically refractory chronic rhinosinusitis. Middle meatus spacers are currently used following ESS to prevent...
Eligibility Criteria
Inclusion
- aged 18 and older
- diagnosis of chronic rhinosinusitis based on the 2016 International Consensus Statement on Allergy and Rhinology: Rhinosinusitis definition
- failed a trial of previous medical therapy
- have bilateral sinus disease on CT imaging
- will undergo bilateral endoscopic sinus surgery.
Exclusion
- unable to give informed consent
- not a candidate for endoscopic sinus surgery
Key Trial Info
Start Date :
January 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04841343
Start Date
January 29 2021
End Date
September 30 2022
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Medical Center
Los Angeles, California, United States, 90095